Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AMTX - Aemetis Inc


IEX Last Trade
2.46
-0.030   -1.220%

Share volume: 217,913
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$2.49
-0.03
-1.21%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-6.82%
1 Month
-28.07%
3 Months
-30.90%
6 Months
-29.71%
1 Year
-54.36%
2 Year
-71.26%
Key data
Stock price
$2.46
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.10 - $7.03
52 WEEK CHANGE
-$0.50
MARKET CAP 
116.104 M
YIELD 
N/A
SHARES OUTSTANDING 
47.197 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
2.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$356,383
AVERAGE 30 VOLUME 
$525,240
Company detail
CEO: Eric McAfee
Region: US
Website: http://www.aemetis.com/
Employees: 31
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

headquartered in cupertino, california, aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advanced biorefineries. founded in 2006, aemetis owns and operates a 60 million gallon per year ethanol production facility in california’s central valley, near modesto. aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the east coast of india producing high quality distilled biodiesel and refined glycerin for customers in india, the us and europe. aemetis operates a research and development laboratory at the maryland biotech center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. for additional information about aemetis, please visit

Recent news